CWM
BPMC

CIBC World Markets’s Blueprint Medicines BPMC Stock Holding History

CIBC World Markets’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.01M Sell
7,888
-6,221
-44% -$646K 0.01% 663
2025
Q1 		$1.25M Buy
14,109
+8,159
+137% +$796K 0.01% 625
2024
Q4 		$519K Buy
+5,950
New +$545K ﹤0.01% 725

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIBC World Markets's BPMC Position: Q2 2025 in Review

CIBC World Markets reduced its Blueprint Medicines (BPMC) stake by 44% in Q2 2025, selling an estimated $646K and leaving 7,888 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #663.

CIBC World Markets first reported a position in BPMC in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.25M in Q1 2025. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • CIBC World Markets held 7,888 shares of Blueprint Medicines worth $1.01M as of Q2 2025.
  • CIBC World Markets sold 6,221 Blueprint Medicines shares in Q2 2025, an estimated $646K.
  • Blueprint Medicines made up 0.01% of CIBC World Markets's portfolio in Q2 2025, its #663 holding.
  • CIBC World Markets first reported a position in Blueprint Medicines in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's Blueprint Medicines position peaked at $1.25M in Q1 2025.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.